Trientine: Clinical Trials

2 trials of Trientine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1

Follow Trientine: new trials by email Literature Review of Trientine trials Research Report on Trientine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Trientine Hydrochloride, Oral placebo capsules - Diabetic Retinopathy
Not applicableTerminatedUniversity of British Columbia32010-11-012013-05-03
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Once a day Trientine - Wilson Disease
Not applicableCompletedYale University82010-01-012020-04-15

Conditions studied

Diabetic Retinopathy (1)  ·  Hepatolenticular Degeneration (1)  ·  Macular Edema (1)

Sponsors

University of British Columbia (1)  ·  Yale University (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Andrew Merkus (1)  ·  David Albiani (1)  ·  David Maberly (1)  ·  Michael Schilsky, MD (1)  ·  Patrick Ma (1)

Results publications

PMID 25605552